IBEX LTD (IBEX) Stock Fundamental Analysis
NASDAQ:IBEX - BMG4690M1010 - Common Stock
29.19 USD
-0.29 (-0.98%)
29.19 USD
0 (0%)
Taking everything into account, IBEX scores 7 out of 10 in our fundamental rating. IBEX was compared to 83 industry peers in the IT Services industry. IBEX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IBEX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make IBEX suitable for value and quality investing!
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
Each year in the past 5 years IBEX has been profitable.
Each year in the past 5 years IBEX had a positive operating cash flow.
1.2 Ratios
IBEX's Return On Assets of 13.51% is amongst the best of the industry. IBEX outperforms 92.77% of its industry peers.
With an excellent Return On Equity value of 29.89%, IBEX belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
IBEX's Return On Invested Capital of 18.65% is amongst the best of the industry. IBEX outperforms 92.77% of its industry peers.
IBEX had an Average Return On Invested Capital over the past 3 years of 12.81%. This is significantly below the industry average of 22.12%.
The last Return On Invested Capital (18.65%) for IBEX is above the 3 year average (12.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 29.89% | ||
| ROIC | 18.65% |
ROA(3y)9.84%
ROA(5y)7.66%
ROE(3y)20.09%
ROE(5y)24.99%
ROIC(3y)12.81%
ROIC(5y)12.8%
1.3 Margins
IBEX has a better Profit Margin (6.93%) than 71.08% of its industry peers.
In the last couple of years the Profit Margin of IBEX has grown nicely.
The Operating Margin of IBEX (8.88%) is better than 63.86% of its industry peers.
In the last couple of years the Operating Margin of IBEX has grown nicely.
Looking at the Gross Margin, with a value of 30.89%, IBEX is in line with its industry, outperforming 40.96% of the companies in the same industry.
IBEX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.88% | ||
| PM (TTM) | 6.93% | ||
| GM | 30.89% |
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
IBEX has less shares outstanding than it did 1 year ago.
IBEX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IBEX is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.42 indicates that IBEX is not in any danger for bankruptcy at the moment.
IBEX has a Altman-Z score of 4.42. This is in the better half of the industry: IBEX outperforms 71.08% of its industry peers.
IBEX has a debt to FCF ratio of 1.04. This is a very positive value and a sign of high solvency as it would only need 1.04 years to pay back of all of its debts.
IBEX has a Debt to FCF ratio of 1.04. This is amongst the best in the industry. IBEX outperforms 81.93% of its industry peers.
IBEX has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IBEX (0.16) is better than 65.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.04 | ||
| Altman-Z | 4.42 |
ROIC/WACC1.96
WACC9.52%
2.3 Liquidity
A Current Ratio of 1.67 indicates that IBEX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.67, IBEX is in line with its industry, outperforming 48.19% of the companies in the same industry.
IBEX has a Quick Ratio of 1.67. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
IBEX's Quick ratio of 1.67 is in line compared to the rest of the industry. IBEX outperforms 49.40% of its industry peers.
IBEX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 34.22% over the past year.
The Earnings Per Share has been growing by 25.59% on average over the past years. This is a very strong growth
Looking at the last year, IBEX shows a small growth in Revenue. The Revenue has grown by 5.38% in the last year.
The Revenue has been growing slightly by 6.66% on average over the past years.
EPS 1Y (TTM)34.22%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%17.14%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%10.99%
3.2 Future
IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.83% yearly.
Based on estimates for the next years, IBEX will show a small growth in Revenue. The Revenue will grow by 6.63% on average per year.
EPS Next Y24.13%
EPS Next 2Y21.44%
EPS Next 3Y17.83%
EPS Next 5YN/A
Revenue Next Year7.46%
Revenue Next 2Y6.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.63, which indicates a very decent valuation of IBEX.
IBEX's Price/Earnings ratio is rather cheap when compared to the industry. IBEX is cheaper than 86.75% of the companies in the same industry.
When comparing the Price/Earnings ratio of IBEX to the average of the S&P500 Index (27.08), we can say IBEX is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.34, the valuation of IBEX can be described as very reasonable.
92.77% of the companies in the same industry are more expensive than IBEX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, IBEX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.63 | ||
| Fwd PE | 9.34 |
4.2 Price Multiples
89.16% of the companies in the same industry are more expensive than IBEX, based on the Enterprise Value to EBITDA ratio.
IBEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBEX is cheaper than 68.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.79 | ||
| EV/EBITDA | 5.81 |
4.3 Compensation for Growth
IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of IBEX may justify a higher PE ratio.
IBEX's earnings are expected to grow with 17.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)0.45
EPS Next 2Y21.44%
EPS Next 3Y17.83%
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.19
-0.29 (-0.98%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.1%
Inst Owner Change4.61%
Ins Owners9.07%
Ins Owner Change-3.97%
Market Cap390.27M
Analysts45.71
Price Target31.11 (6.58%)
Short Float %1.5%
Short Ratio1.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.71%
Min EPS beat(2)10.89%
Max EPS beat(2)14.54%
EPS beat(4)4
Avg EPS beat(4)10.27%
Min EPS beat(4)7.33%
Max EPS beat(4)14.54%
EPS beat(8)6
Avg EPS beat(8)4.12%
EPS beat(12)9
Avg EPS beat(12)12.36%
EPS beat(16)11
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)3.78%
Min Revenue beat(2)2.45%
Max Revenue beat(2)5.12%
Revenue beat(4)3
Avg Revenue beat(4)2.25%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.13%
Revenue beat(12)3
Avg Revenue beat(12)-1.53%
Revenue beat(16)5
Avg Revenue beat(16)-1.36%
PT rev (1m)0%
PT rev (3m)17.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.78%
EPS NY rev (1m)0%
EPS NY rev (3m)1.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.63 | ||
| Fwd PE | 9.34 | ||
| P/S | 0.73 | ||
| P/FCF | 19.79 | ||
| P/OCF | 11.1 | ||
| P/B | 3.14 | ||
| P/tB | 3.47 | ||
| EV/EBITDA | 5.81 |
EPS(TTM)2.51
EY8.6%
EPS(NY)3.13
Fwd EY10.71%
FCF(TTM)1.47
FCFY5.05%
OCF(TTM)2.63
OCFY9.01%
SpS40.06
BVpS9.29
TBVpS8.4
PEG (NY)0.48
PEG (5Y)0.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 29.89% | ||
| ROCE | 25.63% | ||
| ROIC | 18.65% | ||
| ROICexc | 19.91% | ||
| ROICexgc | 21.22% | ||
| OM | 8.88% | ||
| PM (TTM) | 6.93% | ||
| GM | 30.89% | ||
| FCFM | 3.68% |
ROA(3y)9.84%
ROA(5y)7.66%
ROE(3y)20.09%
ROE(5y)24.99%
ROIC(3y)12.81%
ROIC(5y)12.8%
ROICexc(3y)17.21%
ROICexc(5y)17.42%
ROICexgc(3y)18.84%
ROICexgc(5y)20.06%
ROCE(3y)15.96%
ROCE(5y)15.95%
ROICexcg growth 3Y4.28%
ROICexcg growth 5Y9.56%
ROICexc growth 3Y7.35%
ROICexc growth 5Y13.69%
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.04 | ||
| Debt/EBITDA | 0.3 | ||
| Cap/Depr | 87.74% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | 34.97 | ||
| Cash Conversion | 53.93% | ||
| Profit Quality | 53.13% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.42 |
F-Score6
WACC9.52%
ROIC/WACC1.96
Cap/Depr(3y)96.17%
Cap/Depr(5y)91.5%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.32%
Profit Quality(3y)72.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.22%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%17.14%
EPS Next Y24.13%
EPS Next 2Y21.44%
EPS Next 3Y17.83%
EPS Next 5YN/A
Revenue 1Y (TTM)5.38%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%10.99%
Revenue Next Year7.46%
Revenue Next 2Y6.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.55%
EBIT growth 3Y35.57%
EBIT growth 5Y44.18%
EBIT Next Year91.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.37%
OCF growth 3Y30.7%
OCF growth 5Y74.8%